Characterizing the Use of Time-Limited Trials in Patients With Acute Respiratory Failure: A Prospective,...

Area of Science:

• Critical Care Medicine
• Pulmonology
• Medical Ethics

Background:

• Time-limited trials (TLTs) offer a structured approach to managing uncertainty in critical illness by setting a defined period for life-sustaining therapy.
• The current utilization and patterns of TLTs in patients with acute respiratory failure (ARF) remain largely uncharacterized.

Purpose of the Study:

• To investigate and characterize the use of time-limited trials (TLTs) in adult patients experiencing acute respiratory failure (ARF).

Main Methods:

• A prospective, 12-month observational cohort study was conducted at a U.S. academic medical center.
• Included were adult intensive care unit (ICU) patients with ARF requiring invasive mechanical ventilation for at least 48 hours.
• Data on patient characteristics, care delivery, and outcomes were extracted from electronic medical records, with TLT participation identified by ICU physicians.

Main Results:

• Of 176 eligible patients, 36 (20.5%) participated in a TLT. Physician participation in TLTs varied significantly (0-39% of patients).
• TLT patients were older, had higher comorbidity scores, and were more likely to die or be discharged to hospice (80.6%) compared to non-TLT patients.
• TLT use was associated with a shorter ICU length of stay (median 5.7 days vs. 10.3 days).

Conclusions:

• Approximately one in five patients with ARF engaged in a TLT, predominantly those nearing end of life.
• Significant variation exists among physicians in the application of TLTs.
• There is a clear need for evidence-based guidelines to standardize and optimize the use of TLTs in critical care settings.